Medskan Group, the proprietor of KDL Labs, readies for Initial Public Offering (IPO)
Let's dive into the latest scoop on Medscan, the renowned healthcare firm that operates a network of clinics, labs, and diagnostic centers across Russia. According to RBC and Forbes, Medscan's founder Eugene Tugolukov has hinted at an upcoming IPO, giving us a sneak peek of a potential offer of 10-15% additional shares.
Tugolukov estimated the private medical market to be worth a staggering 8 trillion rubles, with his own Medscan outshining the market's annual growth rate of 10% by recording an impressive 12x increase in revenue since 2020.
When asked about potential investors, Tugolukov showed a welcoming stance, expecting a diverse range from "ordinary citizens who are our clients" promising added perks for those doubling as owners.
Established back in 2013, Medscan has grown its domestic footprint to 65 medical centers, 15 labs, and 451 lab offices in 105 cities. Its operations span beyond regular clinics, encompassing diagnostic centers, hospitals, research centers, and even oncology clinics.
Tugolukov, who holds 50% of the group, shares the other half with Rosatom, through a subsidiary. In 2024, the company raked in a whopping 28 billion rubles, representing a 25% revenue boost.
Medscan has been consistently ranked in the top bracket of private medical companies in Russia. In 2022 and 2023, it secured the second spot for revenue growth, boasting an astonishing 186% growth in 2023 and 96.3% growth in 2022, according to DK.RU. However, the 2024 ranking hasn't been unveiled yet.
In the regions, one of Medscan's most notable assets has been the KDL laboratories, particularly during the COVID-19 pandemic, as they aggressively offered widespread testing, earning recognition from DK.RU for their quick response.
Now, that's what I call a booming healthcare business! Stay tuned for more updates on Medscan's IPO as we dig deeper into the details.
In the context of Medscan's IPO and discussions about potential investors, the founder, Eugene Tugolukov, mentioned that he expects financing from diverse sources, including "ordinary citizens who are our clients," offering additional perks for those who become owners.
With its consistent growth and impressive financial performance, Medscan's upcoming IPO could attract significant investment within the finance sector, given the company's annual growth rate of 10% and a staggering 12x increase in revenue since 2020, reaching a total of 28 billion rubles in 2024.
){kind=link}